Trademark Overview
On Wednesday, June 11, 2025, a trademark application was filed for ZALPHACTRO with the United States Patent and Trademark Office. The USPTO has given the ZALPHACTRO trademark a serial number of 99228668. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, July 18, 2025. This trademark is owned by RayzeBio, Inc.. The ZALPHACTRO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.